Details of the Drug
General Information of Drug (ID: DMPV674)
Drug Name |
7-(2-Amino-ethyl)-4-hydroxy-3H-benzothiazol-2-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL17357; 108773-04-2; 7-(2-Amino-ethyl)-4-hydroxy-3H-benzothiazol-2-one; SCHEMBL4740762; 2(3H)-BENZOTHIAZOLONE,7-(2-AMINOETHYL)-4-HYDROXY-; ZINC26894070; BDBM50020679; AKOS027394867; KB-293910; 7-(2-Aminoethyl)-1,3-benzothiazole-2,4-diol; 2(3H)-Benzothiazolone, 7-(2-aminoethyl)-4-hydroxy-
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 210.26 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 0.6 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References